在多个中心的儿科放射治疗中融入视听熏陶:放射治疗中的视听辅助治疗环境前瞻性多机构试验的方法、及时性和成本

IF 2.2 Q3 ONCOLOGY Advances in Radiation Oncology Pub Date : 2024-08-10 DOI:10.1016/j.adro.2024.101589
Justin Oh MD , Lawrie Skinner PhD , Paulina M. Gutkin BS , Alice Jiang BA , Sarah S. Donaldson MD , Billy W. Loo Jr MD, PhD , Yi Peng Wang BA , Agnes Ewongwo MD , Jeremy S. Bredfeldt PhD , John C. Breneman MD , Louis S. Constine MD , Austin M. Faught PhD , Daphne Haas-Kogan MD , Jordan A. Holmes MD , Matthew Krasin MD , Charlene Larkin CCLS , Karen J. Marcus MD , Peter G. Maxim PhD , Shearwood McClelland III MD , Blair Murphy MD , Susan M. Hiniker MD
{"title":"在多个中心的儿科放射治疗中融入视听熏陶:放射治疗中的视听辅助治疗环境前瞻性多机构试验的方法、及时性和成本","authors":"Justin Oh MD ,&nbsp;Lawrie Skinner PhD ,&nbsp;Paulina M. Gutkin BS ,&nbsp;Alice Jiang BA ,&nbsp;Sarah S. Donaldson MD ,&nbsp;Billy W. Loo Jr MD, PhD ,&nbsp;Yi Peng Wang BA ,&nbsp;Agnes Ewongwo MD ,&nbsp;Jeremy S. Bredfeldt PhD ,&nbsp;John C. Breneman MD ,&nbsp;Louis S. Constine MD ,&nbsp;Austin M. Faught PhD ,&nbsp;Daphne Haas-Kogan MD ,&nbsp;Jordan A. Holmes MD ,&nbsp;Matthew Krasin MD ,&nbsp;Charlene Larkin CCLS ,&nbsp;Karen J. Marcus MD ,&nbsp;Peter G. Maxim PhD ,&nbsp;Shearwood McClelland III MD ,&nbsp;Blair Murphy MD ,&nbsp;Susan M. Hiniker MD","doi":"10.1016/j.adro.2024.101589","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><p>The Audiovisual-Assisted Therapeutic Ambience in Radiotherapy (AVATAR) trial was a prospective multicenter study (NCT03991156) examining the combination of video immersion with radiation therapy and was successfully conducted through the collaboration of pediatric radiation oncology teams at 10 institutions independent of any pre-existing consortium. We sought to analyze and report the methodology of trial conception and development, process map, and cost.</p></div><div><h3>Methods and Materials</h3><p>The study enrolled patients aged 3 to 10 years preparing to undergo radiation therapy, integrated the combination of AVATAR-based video immersion with radiation therapy at each institution, and offered AVATAR use as an alternative to anesthesia, with rates of anesthesia use and outcomes of serial standardized anxiety and quality-of-life assessments assessed among the 81 children enrolled. A process map was created based on the trial timeline with the following components: study development time (time from conception of the trial to the accrual of the first patient, including design phase, agreement and approval phase, and site preparation phase), and accrual duration time (time from the first to last accrual). Costs and institutional success rates were calculated.</p></div><div><h3>Results</h3><p>Time from inception of study to last accrual was 3.6 years (1313 days). The study development time was 417 days (31.7%), and accrual duration time was 896 days (68.3%), with the final 50% of accrual occurring in &lt;6 months. Equipment cost was approximately $550 per institution and was covered by funding from the lead study institution. All 10 centers were successful with AVATAR implementation, defined as ≥50% of patients able to avoid anesthesia with the use of AVATAR, including centers with both photon and proton therapy.</p></div><div><h3>Conclusions</h3><p>This report elaborates on the methodology and timeline of trial conception and development using data from a previously published supportive care study combining video immersion with radiation therapy among 10 cooperating pediatric oncology institutions. It highlights the potential for multicenter collaborations on prospective trials integrating supportive care therapies with radiation therapy.</p></div>","PeriodicalId":7390,"journal":{"name":"Advances in Radiation Oncology","volume":"9 10","pages":"Article 101589"},"PeriodicalIF":2.2000,"publicationDate":"2024-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2452109424001520/pdfft?md5=9bbf4f3a7436f5d11219015d149b5337&pid=1-s2.0-S2452109424001520-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial\",\"authors\":\"Justin Oh MD ,&nbsp;Lawrie Skinner PhD ,&nbsp;Paulina M. Gutkin BS ,&nbsp;Alice Jiang BA ,&nbsp;Sarah S. Donaldson MD ,&nbsp;Billy W. Loo Jr MD, PhD ,&nbsp;Yi Peng Wang BA ,&nbsp;Agnes Ewongwo MD ,&nbsp;Jeremy S. Bredfeldt PhD ,&nbsp;John C. Breneman MD ,&nbsp;Louis S. Constine MD ,&nbsp;Austin M. Faught PhD ,&nbsp;Daphne Haas-Kogan MD ,&nbsp;Jordan A. Holmes MD ,&nbsp;Matthew Krasin MD ,&nbsp;Charlene Larkin CCLS ,&nbsp;Karen J. Marcus MD ,&nbsp;Peter G. Maxim PhD ,&nbsp;Shearwood McClelland III MD ,&nbsp;Blair Murphy MD ,&nbsp;Susan M. Hiniker MD\",\"doi\":\"10.1016/j.adro.2024.101589\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Purpose</h3><p>The Audiovisual-Assisted Therapeutic Ambience in Radiotherapy (AVATAR) trial was a prospective multicenter study (NCT03991156) examining the combination of video immersion with radiation therapy and was successfully conducted through the collaboration of pediatric radiation oncology teams at 10 institutions independent of any pre-existing consortium. We sought to analyze and report the methodology of trial conception and development, process map, and cost.</p></div><div><h3>Methods and Materials</h3><p>The study enrolled patients aged 3 to 10 years preparing to undergo radiation therapy, integrated the combination of AVATAR-based video immersion with radiation therapy at each institution, and offered AVATAR use as an alternative to anesthesia, with rates of anesthesia use and outcomes of serial standardized anxiety and quality-of-life assessments assessed among the 81 children enrolled. A process map was created based on the trial timeline with the following components: study development time (time from conception of the trial to the accrual of the first patient, including design phase, agreement and approval phase, and site preparation phase), and accrual duration time (time from the first to last accrual). Costs and institutional success rates were calculated.</p></div><div><h3>Results</h3><p>Time from inception of study to last accrual was 3.6 years (1313 days). The study development time was 417 days (31.7%), and accrual duration time was 896 days (68.3%), with the final 50% of accrual occurring in &lt;6 months. Equipment cost was approximately $550 per institution and was covered by funding from the lead study institution. All 10 centers were successful with AVATAR implementation, defined as ≥50% of patients able to avoid anesthesia with the use of AVATAR, including centers with both photon and proton therapy.</p></div><div><h3>Conclusions</h3><p>This report elaborates on the methodology and timeline of trial conception and development using data from a previously published supportive care study combining video immersion with radiation therapy among 10 cooperating pediatric oncology institutions. It highlights the potential for multicenter collaborations on prospective trials integrating supportive care therapies with radiation therapy.</p></div>\",\"PeriodicalId\":7390,\"journal\":{\"name\":\"Advances in Radiation Oncology\",\"volume\":\"9 10\",\"pages\":\"Article 101589\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-08-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2452109424001520/pdfft?md5=9bbf4f3a7436f5d11219015d149b5337&pid=1-s2.0-S2452109424001520-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Radiation Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2452109424001520\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452109424001520","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

目的放疗中的视听辅助治疗环境(AVATAR)试验是一项前瞻性多中心研究(NCT03991156),旨在检查视频沉浸疗法与放疗的结合情况,该试验由 10 家机构的儿科放射肿瘤团队合作成功开展,与任何预先存在的联盟无关。我们试图分析和报告试验的构思和开发方法、流程图和成本。方法和材料该研究招募了准备接受放射治疗的 3 至 10 岁患者,在每个机构将基于 AVATAR 的视频沉浸与放射治疗相结合,并提供 AVATAR 作为麻醉的替代方法,评估了 81 名入选儿童的麻醉使用率以及连续标准化焦虑和生活质量评估的结果。根据试验时间表绘制了流程图,其中包括以下部分:研究开发时间(从试验构想到招募第一名患者的时间,包括设计阶段、协议和审批阶段以及场地准备阶段)和招募持续时间(从首次招募到最后一次招募的时间)。计算了成本和机构成功率。结果从研究开始到最后一名患者产生的时间为 3.6 年(1313 天)。研究开发时间为 417 天(31.7%),应计持续时间为 896 天(68.3%),最后 50%的应计发生在 6 个月内。每个机构的设备成本约为 550 美元,由牵头研究机构出资支付。所有 10 个中心都成功实施了 AVATAR,即≥50% 的患者可以通过使用 AVATAR 避免麻醉,其中包括同时进行光子和质子治疗的中心。结论 本报告利用之前发表的一项支持性治疗研究的数据,详细阐述了试验构思和开发的方法和时间表,该研究将视频沉浸与放射治疗相结合,在 10 个合作的儿科肿瘤机构中进行。报告强调了多中心合作开展前瞻性试验的潜力,这些试验将支持性护理疗法与放射治疗相结合。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Integrating Audiovisual Immersion Into Pediatric Radiation Therapy Across Multiple Centers: Methodology, Timeliness, and Cost of the Audiovisual-Assisted Therapeutic Ambience in Radiation Therapy Prospective Multi-Institutional Trial

Purpose

The Audiovisual-Assisted Therapeutic Ambience in Radiotherapy (AVATAR) trial was a prospective multicenter study (NCT03991156) examining the combination of video immersion with radiation therapy and was successfully conducted through the collaboration of pediatric radiation oncology teams at 10 institutions independent of any pre-existing consortium. We sought to analyze and report the methodology of trial conception and development, process map, and cost.

Methods and Materials

The study enrolled patients aged 3 to 10 years preparing to undergo radiation therapy, integrated the combination of AVATAR-based video immersion with radiation therapy at each institution, and offered AVATAR use as an alternative to anesthesia, with rates of anesthesia use and outcomes of serial standardized anxiety and quality-of-life assessments assessed among the 81 children enrolled. A process map was created based on the trial timeline with the following components: study development time (time from conception of the trial to the accrual of the first patient, including design phase, agreement and approval phase, and site preparation phase), and accrual duration time (time from the first to last accrual). Costs and institutional success rates were calculated.

Results

Time from inception of study to last accrual was 3.6 years (1313 days). The study development time was 417 days (31.7%), and accrual duration time was 896 days (68.3%), with the final 50% of accrual occurring in <6 months. Equipment cost was approximately $550 per institution and was covered by funding from the lead study institution. All 10 centers were successful with AVATAR implementation, defined as ≥50% of patients able to avoid anesthesia with the use of AVATAR, including centers with both photon and proton therapy.

Conclusions

This report elaborates on the methodology and timeline of trial conception and development using data from a previously published supportive care study combining video immersion with radiation therapy among 10 cooperating pediatric oncology institutions. It highlights the potential for multicenter collaborations on prospective trials integrating supportive care therapies with radiation therapy.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in Radiation Oncology
Advances in Radiation Oncology Medicine-Radiology, Nuclear Medicine and Imaging
CiteScore
4.60
自引率
4.30%
发文量
208
审稿时长
98 days
期刊介绍: The purpose of Advances is to provide information for clinicians who use radiation therapy by publishing: Clinical trial reports and reanalyses. Basic science original reports. Manuscripts examining health services research, comparative and cost effectiveness research, and systematic reviews. Case reports documenting unusual problems and solutions. High quality multi and single institutional series, as well as other novel retrospective hypothesis generating series. Timely critical reviews on important topics in radiation oncology, such as side effects. Articles reporting the natural history of disease and patterns of failure, particularly as they relate to treatment volume delineation. Articles on safety and quality in radiation therapy. Essays on clinical experience. Articles on practice transformation in radiation oncology, in particular: Aspects of health policy that may impact the future practice of radiation oncology. How information technology, such as data analytics and systems innovations, will change radiation oncology practice. Articles on imaging as they relate to radiation therapy treatment.
期刊最新文献
Benefit of Avasopasem Manganese on Severe Oral Mucositis in Head and Neck Cancer in the ROMAN Trial: Unplanned Secondary Analysis A Predictive Nomogram for Development of Lymph Node Metastasis in Muscle-Invasive Bladder Cancer Following Neoadjuvant Therapy Outcomes After Stereotactic Body Radiation for Hepatocellular Carcinoma in Patients With Child-Pugh A Versus Child-Pugh B/C Cirrhosis Non-Small Cell Lung Cancer With Brain Metastases and Concomitant Listeria Monocytogenes Brain Abscesses Editorial board
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1